Therapeutic agent for treating Trypanosoma-associated disease, method for killing Trypanosoma parasites, and use thereof
AssigneeRiken
InventorsKatsuhiko Mikoshiba, Takeshi Nara, Muneaki Hashimoto
Life of this patent
Estimating the term…
Abstract
A therapeutic agent for treating a Trypanosoma-associated disease; a method of preventing infection by Trypanosoma parasites, or killing Trypanosoma parasites; and use thereof, the therapeutic agent and the method each using a mechanism different from a mechanism used in conventional technology. The therapeutic agent of the present invention for treating a Trypanosoma-associated disease includes, as a medicinal component, an antisense oligonucleotide suppressing the expression of an inositol 1,4,5-trisphosphate receptor protein of Trypanosoma parasites.
Claims4
A therapeutic agent for treating a Trypanosoma-associated disease, comprising, as a medicinal component, a therapeutically effective amount of a synthesized antisense oligonucleotide suppressing the expression of an inositol 1,4,5-trisphosphate receptor protein of Trypanosoma parasites,
- wherein the therapeutic agent further comprises at least a preservative.
A drug for suppressing the expression of an inositol 1,4,5-trisphosphate receptor protein of Trypanosoma parasites, comprising, as an active component, an effective amount of a synthesized antisense oligonucleotide suppressing the expression of the inositol 1,4,5-trisphosphate receptor protein,
- wherein the drug further comprises at least a preservative.
Dependencies are inferred from the claim text.